TP53 and cancer: Various cell lines are used to investigate hypoxia effect on cell viability including non-cancerous cells (primary hepatocytes, L02, MCF-10A), less malignant cancer cells (p53 wild type HepG2 and SMMC-7721), highly malignant cancer cells (p53 mutant Huh7 and MDA-MB-231).